News

Shree Ganesh Remedies Limited will close its trading window for securities transactions from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half-year ended September 30, 2026, in compliance with Securities and Exchange Board of India regulations.

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Net profit of Shree Ganesh Remedies declined 4.86% to Rs 6.27 crore in the quarter ended March 2026 as against Rs 6.59 crore during the previous quarter ended March 2025. Sales rose 35.90% to Rs 33.20 crore in the quarter ended March 2026 as against Rs 24.43 crore during the previous quarter ended March 2025.For the full year,net profit declined 23.02% to Rs 17.76 crore in the year ended March 2026 as against Rs 23.07 crore during the previous year ended March 2025. Sales rose 0.64% to Rs 109.29 crore in the year ended March 2026 as against Rs 108.60 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales33.2024.43 36 109.29108.60 1 OPM %34.2840.40 -32.0436.10 - PBDT11.5211.20 3 34.4940.83 -16 PBT8.728.77 -1 24.0131.27 -23 NP6.276.59 -5 17.7623.07 -23 Powered by Capital Market - Live News

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Shree Ganesh Remedies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 April 2026.Powered by Capital Market - Live News